Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Respir Crit Care Med ; 157(5 Pt 1): 1372-80, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9603111

RESUMO

A randomized, controlled clinical trial was performed with patients with acute respiratory distress syndrome (ARDS) to compare the effect of conventional therapy or inhaled nitric oxide (iNO) on oxygenation. Patients were randomized to either conventional therapy or conventional therapy plus iNO for 72 h. We tested the following hypotheses: (1) that iNO would improve oxygenation during the 72 h after randomization, as compared with conventional therapy; and (2) that iNO would increase the likelihood that patients would improve to the extent that the FI(O2) could be decreased by > or = 0.15 within 72 h after randomization. There were two major findings. First, That iNO as compared with conventional therapy increased Pa(O2)/FI(O2) at 1 h, 12 h, and possibly 24 h. Beyond 24 h, the two groups had an equivalent improvement in Pa(O2)/FI(O2). Second, that patients treated with iNO therapy were no more likely to improve so that they could be managed with a persistent decrease in FI(O2) > or = 0.15 during the 72 h following randomization (11 of 20 patients with iNO versus 9 of 20 patients with conventional therapy, p = 0.55). In patients with severe ARDS, our results indicate that iNO does not lead to a sustained improvement in oxygenation as compared with conventional therapy.


Assuntos
Óxido Nítrico/administração & dosagem , Oxigênio/sangue , Síndrome do Desconforto Respiratório/terapia , Administração por Inalação , Adolescente , Adulto , Idoso , Pré-Escolar , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Óxido Nítrico/efeitos adversos , Respiração Artificial , Síndrome do Desconforto Respiratório/sangue , Resultado do Tratamento
2.
J Infect Dis ; 157(2): 272-9, 1988 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2891775

RESUMO

Shock, a common and frequently fatal manifestation of gas gangrene caused by Clostridium perfringens, is probably mediated by extracellular toxins. Previous studies implicating alpha-toxin as the major lethal factor were frequently done with preparations contaminated with a second lethal factor, theta-toxin. We purified alpha- and theta-toxins from C. perfringens and demonstrated that both were lethal to mice. We investigated the effects of these purified toxins on cardiovascular function in intact rabbits; both toxins caused profound hypotension and bradycardia within 40 min. Reduced cardiac output preceded the development of hypotension and bradycardia. Purified alpha-toxin produced a dose-dependent reduction in myocardial function in isolated rabbit atrial preparations. Purified theta-toxin did not directly inhibit myocardial function. Shock induced by alpha-toxin may be partly mediated by direct depression of myocardial function. theta-Toxin reduced cardiac output in intact animals but had no direct effects on isolated heart preparations at concentrations that induced shock in intact animals. These data suggest that theta-toxin-induced shock could be mediated by an endogenous myocardial depressant factor.


Assuntos
Toxinas Bacterianas/toxicidade , Proteínas de Ligação ao Cálcio , Clostridium perfringens , Gangrena Gasosa/complicações , Hemodinâmica/efeitos dos fármacos , Choque Séptico/etiologia , Fosfolipases Tipo C , Animais , Pressão Sanguínea/efeitos dos fármacos , Débito Cardíaco/efeitos dos fármacos , Feminino , Coração/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Proteínas Hemolisinas/toxicidade , Masculino , Camundongos , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA